Literature DB >> 21118715

Impact of obesity on hypertension-induced cardiac remodeling: role of oxidative stress and its modulation by gemfibrozil treatment in rats.

Randhir Singh1, Amrit Pal Singh, Manjeet Singh, Pawan Krishan.   

Abstract

This study investigated the possible synergistic role of obesity in hypertension-induced cardiac remodeling and its modulation by gemfibrozil treatment in rats. Male Wistar rats were fed a high-fat diet (HFD) for 90 days. Normal rats were subjected to hypertension by partial abdominal aortic constriction (PAAC) for 28 days. In the HFD+PAAC control group, rats on HFD were subjected to PAAC on the 62nd day and were sacrificed on the 90th day. HFD and PAAC individually resulted in significant cardiac hypertrophy and fibrosis along with increased oxidative stress and mean arterial blood pressure (MABP) in rats as evidenced by various morphological, biochemical, and histological parameters. Moreover, the HFD + PAAC control group showed marked cardiac remodeling compared to rats subjected to HFD or PAAC alone. The HFD+gemfibrozil and HFD+PAAC+gemfibrozil groups showed significant reduction in cardiac remodeling along with reduction in oxidative stress and MABP. Hence, it may be concluded that oxidative stress plays a key role in obesity-mediated synergistic effects on induction and progression of PAAC-induced cardiac remodeling, and its deleterious effects could be reversed by gemfibrozil treatment in rats through its antioxidant activity.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21118715     DOI: 10.1016/j.freeradbiomed.2010.11.020

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  5 in total

1.  CARD9 knockout ameliorates myocardial dysfunction associated with high fat diet-induced obesity.

Authors:  Li Cao; Xing Qin; Matthew R Peterson; Samantha E Haller; Kayla A Wilson; Nan Hu; Xin Lin; Sreejayan Nair; Jun Ren; Guanglong He
Journal:  J Mol Cell Cardiol       Date:  2016-02-17       Impact factor: 5.000

2.  Role of GABAergic activity of sodium valproate against ischemia-reperfusion-induced acute kidney injury in rats.

Authors:  Ramanpreet Brar; Jaswinder Pal Singh; Tajpreet Kaur; Saroj Arora; Amrit Pal Singh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-10-24       Impact factor: 3.000

3.  Sinapic acid attenuates cisplatin-induced nephrotoxicity through peroxisome proliferator-activated receptor gamma agonism in rats.

Authors:  Hardevinder Pal Singh; Thakur Gurjeet Singh; Randhir Singh
Journal:  J Pharm Bioallied Sci       Date:  2020-04-10

4.  Celecoxib prevents pressure overload-induced cardiac hypertrophy and dysfunction by inhibiting inflammation, apoptosis and oxidative stress.

Authors:  Chi Zhang; Fan Wang; Yingxia Zhang; Yimin Kang; Haisheng Wang; Mingming Si; Liping Su; Xue Xin; Feng Xue; Fei Hao; Lechu Yu; Jinzhong Xu; Yanlong Liu; Mingming Xue
Journal:  J Cell Mol Med       Date:  2015-10-29       Impact factor: 5.310

5.  FNDC5 attenuates obesity-induced cardiac hypertrophy by inactivating JAK2/STAT3-associated inflammation and oxidative stress.

Authors:  Zhi Geng; Wen-Yong Fan; Bing Zhou; Chao Ye; Ying Tong; Ye-Bo Zhou; Xiao-Qing Xiong
Journal:  J Transl Med       Date:  2019-04-02       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.